US FDA allows 23andMe to sell test for 3 mutations of breast cancer gene

US FDA allows 23andMe to sell test for 3 mutations of breast cancer gene  Reuters 23andMe can now tell you about your breast cancer risk  Business Insider FDA Authorizes 23andMe DTC Test Report for Three BRCA Mutations  GenomeWebFull coverage

Read More ...
US FDA allows 23andMe to sell test for 3 mutations of breast cancer gene published March 06, 2018 at 11:31PM. Original Source Link : https://www.reuters.com/article/us-23andme-fda/u-s-fda-allows-23andme-to-sell-test-for-3-mutations-of-breast-cancer-gene-idUSKCN1GI24I

loading...